MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

The Journal of Computational Biophysics and Chemistry, published by World Scientific Publishing Co. Pte Ltd, is a distinguished platform dedicated to advancing the fields of biophysics and computational chemistry. With an ISSN of 2737-4165 and an E-ISSN of 2737-4173, this journal has garnered attention since its inception, earning a Q3 ranking in Computational Theory and Mathematics and Q4 rankings in both Computer Science Applications and Physical and Theoretical Chemistry as of 2023. The scope of the journal encompasses innovative research that integrates computational techniques with biochemical applications, making it essential reading for researchers, professionals, and students alike. With open access options available, the journal ensures that cutting-edge findings are easily accessible to a global audience, thereby fostering collaboration and innovation in the scientific community. Based in Singapore, the journal aims to converge ideas and methodologies from 2021 to 2024, paving the way for transformative insights in computational methods. Join a community at the forefront of research and applications that bridge disciplines through rigorous scholarship and pioneering discoveries.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING, published by Elsevier Science Inc, is a leading peer-reviewed journal dedicated to the fields of molecular graphics and modeling. With an ISSN of 1093-3263 and an E-ISSN of 1873-4243, this journal has established its relevance since its inception in 1997, and continues to thrive as it extends its scope into 2024. Acknowledged for its impact in the academic community, it holds a Q2 ranking in both Computer Graphics and Computer-Aided Design and Materials Chemistry, as well as a Q3 ranking in Physical and Theoretical Chemistry and Spectroscopy, reflecting its significance across multidisciplinary research domains. Notably, the journal ranks in the 73rd percentile for Computer Graphics and maintains competitive standings in Materials Science and Chemistry areas. Although it does not currently offer open access options, the journal is an essential resource for researchers, professionals, and students who are engaged in cutting-edge studies and applications in molecular graphics, computational methods, and material design. By facilitating a deeper understanding of molecular interactions through innovative graphical modeling, the journal contributes significantly to advancements in science and technology.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.

CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.

Drug Design Development and Therapy is a premier open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of drug discovery, pharmaceutical science, and pharmacology. With an impressive Q1 ranking in its categories as of 2023, this journal is recognized for its significant contributions to the understanding of drug design and therapeutic innovations, making it an invaluable resource for researchers, professionals, and students alike. Established in 2007 and committed to open-access since 2008, the journal provides an inclusive platform for disseminating high-quality research from around the globe. With a robust impact factor and remarkable Scopus rankings, including a 24th place in Pharmaceutical Science and a 48th place in Pharmacology, it reflects a strong percentile performance, ensuring that published articles reach and impact a wide audience. By fostering the exchange of cutting-edge information on drug development and delivery systems, Drug Design Development and Therapy continues to play a crucial role in the ongoing battle against disease, promoting innovative approaches to therapeutic solutions and enhancing patient care.

Wiley Interdisciplinary Reviews: Computational Molecular Science is a premier journal published by WILEY, dedicated to the intersection of computational techniques and molecular science. Boasting an impressive impact factor and consistently ranking in the Q1 category across several key disciplines including Biochemistry, Computational Mathematics, Computer Science Applications, Materials Chemistry, and Physical and Theoretical Chemistry, this journal plays a crucial role in disseminating high-quality research that bridges multiple fields. With its focus on providing a platform for interdisciplinary dialogue and innovative computational solutions, it serves as an essential resource for researchers, professionals, and students eager to push the boundaries of molecular science. While the journal does not currently offer open access, it remains a vital conduit for scholarly communication, fostering advancements in understanding molecular interactions through computational methods. The journal is based in the United States, contributing to its global outreach and impact in the scientific community.

DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.

Current Research in Structural Biology, published by Elsevier, is a pioneering Open Access journal that has rapidly gained prominence since its inception in 2019. With a focus on advancing the understanding of molecular and structural biology, this journal provides a platform for researchers and professionals to publish groundbreaking findings that contribute to the field's ongoing development. With a commendable Q2 ranking in both Molecular Biology and Structural Biology categories for 2023, it serves as a vital resource for the community, ensuring accessibility to high-quality research. The journal is indexed in Scopus, showcasing its significant impact and relevance, particularly with a ranking of #26/49 in the Structural Biology discipline. Located in the heart of the Netherlands, Current Research in Structural Biology not only fosters academic discourse but also encourages collaborative research efforts in addressing critical biological questions. Whether you are a researcher, student, or industry professional, this journal is essential for staying abreast of the latest advancements and trends in structural biology.